We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$703M
AUM Growth
+$44.2M
Cap. Flow
+$32.7K
Cap. Flow %
0%
Top 10 Hldgs %
21.9%
Holding
255
New
4
Increased
50
Reduced
124
Closed
5

Top Buys

Rank Stock Value
1
MIDD icon
Middleby
MIDD
+$3.64M
2
THD icon
iShares MSCI Thailand ETF
THD
+$1.42M
3
EBAY icon
eBay
EBAY
+$845K
4
FAST icon
Fastenal
FAST
+$780K
5
IWC icon
iShares Micro-Cap ETF
IWC
+$600K

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$1.01M
2
TXT icon
Textron
TXT
+$686K
3
APD icon
Air Products & Chemicals
APD
+$642K
4
JNJ icon
Johnson & Johnson
JNJ
+$604K
5
RTX icon
RTX Corp
RTX
+$377K

Sector Composition

Rank Sector Weight
1 Healthcare 16.42%
2 Industrials 13.18%
3 Technology 12.26%
4 Consumer Staples 10.43%
5 Energy 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAB icon
76
Wabtec
WAB
$49.9B
$3.13M 0.44%
49,705
+525
+1% +$30.8K
QCOM icon
77
Qualcomm
QCOM
$168B
$3.01M 0.43%
44,775
-785
-2% -$51.5K
WOLF icon
78
Wolfspeed
WOLF
$1.43B
$2.99M 0.43%
49,683
-900
-2% -$57.3K
ESV
79
DELISTED
Ensco Rowan plc
ESV
$2.9M 0.41%
13,501
LOW icon
80
Lowe's Companies
LOW
$122B
$2.78M 0.4%
58,409
-1,250
-2% -$56.7K
JPM icon
81
JPMorgan Chase
JPM
$947B
$2.75M 0.39%
53,274
-100
-0.2% -$5.36K
MO icon
82
Altria Group
MO
$113B
$2.69M 0.38%
78,221
-1,000
-1% -$35.2K
VIVO
83
DELISTED
Meridian Bioscience Inc
VIVO
$2.44M 0.35%
103,185
+3,585
+4% +$83.7K
D icon
84
Dominion Energy
D
$58.8B
$2.41M 0.34%
38,570
DEO icon
85
Diageo
DEO
$51.6B
$2.34M 0.33%
18,442
-113
-0.6% -$14.1K
AXP icon
86
American Express
AXP
$231B
$2.31M 0.33%
30,580
-225
-0.7% -$16.9K
BMY icon
87
Bristol-Myers Squibb
BMY
$131B
$2.26M 0.32%
48,865
-500
-1% -$21.9K
HUB.B
88
DELISTED
HUBBELL INC CL-B
HUB.B
$2.26M 0.32%
21,570
-350
-2% -$36.8K
RDS.A
89
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.22M 0.32%
36,226
-432
-1% -$26.4K
CVS icon
90
CVS Health
CVS
$123B
$2.19M 0.31%
38,643
-1,012
-3% -$60.3K
AKAM icon
91
Akamai
AKAM
$17.2B
$2.12M 0.3%
40,946
-250
-0.6% -$11.8K
MHFI
92
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$2.07M 0.29%
31,500
EBAY icon
93
eBay
EBAY
$48.9B
$2.04M 0.29%
86,795
+37,683
+77% +$845K
INTC icon
94
Intel
INTC
$503B
$2.01M 0.29%
87,674
-117
-0.1% -$2.69K
THD icon
95
iShares MSCI Thailand ETF
THD
$368M
$2M 0.29%
26,868
+18,764
+232% +$1.42M
APC
96
DELISTED
Anadarko Petroleum
APC
$1.97M 0.28%
21,193
TMO icon
97
Thermo Fisher Scientific
TMO
$214B
$1.9M 0.27%
20,635
-75
-0.4% -$6.78K
K
98
DELISTED
Kellanova
K
$1.89M 0.27%
34,330
-442
-1% -$26.4K
SHW icon
99
Sherwin-Williams
SHW
$88.2B
$1.85M 0.26%
30,510
-45
-0.1% -$2.64K
KMP
100
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$1.84M 0.26%
23,042
-100
-0.4% -$8.28K

Similar funds

Boston Family Office's Q3 2013 Portfolio in Review

As of Q3 2013, Boston Family Office held 255 positions worth $703M, up 6.7% from $659M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q3 2013: portfolio turnover was 3.5%. Boston Family Office opened 4 new positions and exited 5, leaving the 255-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q3 2013 buy was Fastenal: 65,860 shares worth $828K.
  • Boston Family Office added most to Middleby in Q3 2013, an estimated $3.64M increase.
  • Boston Family Office's biggest Q3 2013 reduction was Ansys, cutting an estimated $1.01M.
  • Boston Family Office fully exited Textron in Q3 2013, selling an estimated $686K.
  • Boston Family Office's ten largest holdings make up 22% of its $703M portfolio in Q3 2013.
  • Boston Family Office opened 4 new positions and closed 5 in Q3 2013.
  • Boston Family Office's portfolio value rose 6.7% quarter-over-quarter to $703M.

Based on Boston Family Office's 13F filing for Q3 2013, filed 4 Nov 2013.